Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parasternal Block for Respiratory Function in Cardiac Surgery
NCT05515809Phase 3Active, not recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Jul 2022
- Primary completion
- Jun 2025
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pulmonary complications (PPC), sponsored by CHU Amiens-Picardie. Started Jul 2022; status: active, not recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT05515809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05515809.